Rotation thromboelastography (ROTEM) parameters are influenced by age, gender, and oral contraception

Perfusion

Volumn 26, Issue 4, 2011, Pages 334-340

  Sucker, C ^a   Tharra, K ^b   Litmathe, J ^b   Scharfv, R E ^b   Zotz, R B ^c  

^a LaboMed Coagulation Centre   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^c Centre for Blood Coagulation and Transfusion Medicine   (Germany)

Author keywords

Age; Gender; Oral contraception; Reference values; Rotation thromboelastography; ROTEM

Indexed keywords

ADULT; AGE; ARTICLE; BLOOD CLOTTING; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENDER; HEMOSTASIS; HORMONE SUBSTITUTION; HUMAN; MALE; NORMAL HUMAN; ORAL CONTRACEPTION; PRIORITY JOURNAL; ROTATION THROMBOELASTOGRAPHY; THROMBOELASTOGRAPHY;

ADULT; AGE FACTORS; BLOOD COAGULATION; COHORT STUDIES; CONTRACEPTIVES, ORAL; FEMALE; HEMOSTASIS; HORMONE REPLACEMENT THERAPY; HUMANS; MALE; MIDDLE AGED; OBSERVER VARIATION; SEX FACTORS; THROMBELASTOGRAPHY;

EID: 79960080622     PISSN: 02676591     EISSN: 1477111X     Source Type: Journal    
DOI: 10.1177/0267659111407695     Document Type: Article

References (36)

1. Hartert H. Blutgerinnungsstudien mit der Thrombelastographie, einem neuen Untersuchungsverfahren. Klin Wochenschr 1948; 26: 577-583.
2. Zuckerman L, Cohen E, Vagher JP: Comparison of thromboelastography with common coagulation tests. Thromb Hemost 1981; 46: 752-756. (Pubitemid 12198353)
3. Chandler WL. The thrombelastography and the thrombelastograph technique. Seminars Thromb Hemost 1995; 21 Suppl 4: 1-6.
4. Calatzis AN, Fritzsche P, Calatzis AL, Kling M, Hipp R, Sternberger A. A comparison of the technical principle of the ROTEM coagulation analyser and conventional thrombelastographic systems. Ann Hematol 1996; 72 (suppl 1): 87.
5. Spiess BD, Gilies BS, Chandler W, Verrier E. Changes in transfusion therapy and reexploration rate after institution of a blood management program in cardiac surgery patients. J Cardiothorac Vasc Anest 1995; 9: 168-173.
6. Kaufman CR, Dwyer KN, Cruz JD, Dols SJ, Trask AL. Usefulness of thromboelaastography in assessment of trauma patient coagulation. J Trauma 1997; 42: 716-720.
7. Shore-Lesserson L, Manspeizer HE, De Perio M, Francis S, Vela Cantos F, Ergin MA. Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anest Analg 1999; 88: 312-319. (Pubitemid 29070189)
8. Caprini JA, Traverso CI, Arcelus JI. Perspectives on thromboelastography. Semin Thromb. Hemost 1995; 21 (suppl 4): 91-93. (Pubitemid 26015186)
9. Arcelus JI, Traverso CI, Caprini JA. Thromboelastography for the assessment of hypercoagulability during general surgery. Seminars Thromb Hemost 1995; 21 (suppl 4): 21-26. (Pubitemid 26015177)
10. Gravlee GP, Arora S, Lavender W, et al. Predictive value of blood clotting tests in cardiac surgical patients. Ann Thorac Surg 1994; 58: 216-221. (Pubitemid 24243933)
11. Spiess BD, Tuman KJ, McCarthy RJ, DeLaria GA, Schillo R, Ivankovich AD. Thromboelastography as an indicator of post-cardiopulmonary bypass coagulopathies. J Clin Monit 1987; 3: 25-30. (Pubitemid 17010137)
12. Bell CRW, Cox DJA, Murdock PJ, Sullivan ME, Pasi KJ, Morgan RJ. Thrombelastographic evaluation of coagulation in transurethral prostatectomy. Br J Urology 1996; 78: 737-741. (Pubitemid 27414704)
13. Orlikowski CEP, Rocke DA. Coagulation monitoring in the obstetric patient. Int Anesth Clinics 1994; 32: 173-191. (Pubitemid 24266414)
14. Orlikowski CEP, Rocke DA, Murray WB, et al. Thromboelastography changes in pre-eclampsia and eclampsia. Br J Anaesth 1996; 77: 157-161.
15. Miller BE, Bailey JM, Mancuso TJ, Weinstein MS, et al. Functional maturity of the coagulation system in children; an evaluation using thromboelastography. Anesth Analg 1997; 84: 745-748. (Pubitemid 27147694)
16. Kang Y. Thromboelastography in liver transplantation. Seminars Thromb Hemost 1995; 21 (suppl 4): 34-44. (Pubitemid 26015179)
17. Lang T, Bauters A, Braun SL, et al. Multi-centre investigation on reference ranges for ROTEM thromboelastometry. Blood Coagul Fibrinolysis 2005; 16: 301-310. (Pubitemid 40705054)
18. Daraktchiev AT. Evaluation of a new thrombelastographic method - ROTEM (rotation thrombelastometry). Marburg 2009
19. Kadir RA, Economides DL, Sabin CA, Owens D, Lee CA. Variations in coagulation factors in women: effects of age, ethnicity, menstrual cycle and combined oral contraceptive. Thromb Haemost 1999; 82: 1456-1461. (Pubitemid 29527639)
20. Spitzer WO, Lewis MA, Heinemann LA, Thorogood M, MacRae KD. Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women. BMJ 1996; 312: 83-88.
21. Stadel BV. Oral contraceptives and cardiovascular disease (first of two parts). N Engl J Med 1981; 305: 612-618. (Pubitemid 12201113)
22. Sartwell PE, Masi AT, Arthes FG, Greene GR, Smith HE. Thromboembolism and oral contraceptives: an epidemiologic case-control study. Am J Epidemiol 1969; 90: 365-380.
23. Blomenkamp KW, Rosendaal FR, Helmerhorst FM, Buller HR, Vandenbroucke JP. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen. Lancet 1995; 16: 346: 1593-1596. (Pubitemid 26001841)
24. Gerstman BB, Piper JM, Tomita DK, Ferguson WJ, Stadel BV, Lundin FE. Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease. Am J Epidemiol 1991; 133: 32-37.
25. Grady D, Hulley SB, Furberg C. Venous thromboembolic events associated with hormone replacement therapy. JAMA 1997; 278: 477. (Pubitemid 27343997)
26. Daly E, Vessey MP, Hawkins MM, Carson JL, Gough P, Marsh S. Risk of venous thromboembolism in users of hormone replacement therapy. Lancet 1996;3 48: 977-980. (Pubitemid 26340751)
27. Grodstein F, Stampfer MJ, Goldhaber SZ, et al. Prospective study of exogenous hormones and risk of pulmonary embolism in women. Lancet 1996; 348: 983-987. (Pubitemid 26340753)
28. Jick H, Derby LE, Myers MW, Vasilakis C, Newton KM. Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens. Lancet 1996; 348: 981-983. (Pubitemid 26340752)
29. Zotz RB, Gerhardt A, Scharf RE. New approach for evaluation of quantitative risk factors of venous thromboembolism using individualized reference values. J Thromb Haemost 2005; 3 (suppl 1): abstract OR316.
30. Deguchi K, Deguchi A, Wada H, Murashima S. Study of cardiovascular risk factors and haemostatic molecular markers in elderly persons. Semin Thromb Hemost 2000; 26: 23-27
31. Yee DL, Sun CW, Bergeron AL, Dong JF, Bray PF. Aggregometry detects platelet hyperreactivity in healthy individuals. Blood 2005; 106: 2723-2729. (Pubitemid 41510746)
32. Ng KF. Changes in thrombelastograph variables associated with aging. Anesth Analg 2004; 99: 449-454 (Pubitemid 38970418)
33. Seremetis SV. Sex-related differences in haemostasis and thrombosis. J Gend Specif Med 2001; 4: 59-64.
34. Norris LA, Bonnar J. Haemostatic changes and the oral contraceptive pill. Baillieres Clin Obstet Gynaecol 1997; 11: 545-564. (Pubitemid 27470557)
35. Kluft C, Lansink M. Effect of oral contraceptives on haemostasis variables. Thromb Haemost 1997; 78: 315-326. (Pubitemid 27289261)
36. Martin P, Horkay F, Rajah SM, Walker DR. Monitoring of coagulation status using thromboelastography during paediatric open heart surgery. Int J Clin Monitoring & Computing 1991; 8: 183-187.